Competitive N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)Furan-2-Yl]Quinazolin-4-Amine Bis(4-Methylbenzenesulfonate) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at
+8615651039172
or mail to
sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
As a leading N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)Furan-2-Yl]Quinazolin-4-Amine Bis(4-Methylbenzenesulfonate) supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of N- {3-Chloro-4- [ (3-Fluorobenzyl) Oxy] Phenyl} -6- [5- ({[2- (Methylsulfonyl) Ethyl] Amino} Methyl) Furan-2-Yl] Quinazolin-4-Amine Bis (4-Methylbenzenesulfonate)?
This is an organic compound with a long and complicated name and consists of many parts. To clarify its chemical structure, disassemble and analyze it from each part.
The first of the names "N - {3-chloro-4- [ (3-fluorobenzyl) oxy] phenyl}" indicates the presence of a specific phenyl group in the compound. This benzene is based on the substitution of a chlorine atom at the 3rd position, and the structure modified by a (3-fluorobenzyl) oxygen group at the 4th position.
"6- [5- ({[2- (methylsulfonyl) ethyl] amino} methyl) furan-2-yl] quinazoline-4-amine", the 6-position of the epiquinazoline ring is connected with a substituent containing the furan ring. The 5-position furan ring is structurally modified with [2- (methylsulfonyl) ethyl] aminomethyl, and the 4-position quinazoline is an amine group. After
, "bis (4-methylbenzenesulfonate) " refers to the formation of a diester structure between the compound and 4-methylbenzenesulfonate, which has an impact on the overall chemical and physical properties.
In summary, this compound has a complex structure, consisting of phenyl, quinazoline ring, furan ring and sulfonate parts connected to each other, and the interaction of each part gives the compound unique chemical properties and potential applications. Although the text is difficult to describe in detail, the outline of the structure can also be understood through this disassembly and analysis.
What are the main uses of N- {3-Chloro-4- [ (3-Fluorobenzyl) Oxy] Phenyl} -6- [5- ({[2- (Methylsulfonyl) Ethyl] Amino} Methyl) Furan-2-Yl] Quinazolin-4-Amine Bis (4-Methylbenzenesulfonate)?
This is a complex organic compound named N- {3-chloro-4- [ (3-fluorobenzyl) oxy] phenyl} -6- [5- ({[2- (methylsulfonyl) ethyl] amino} methyl) furan-2-yl] quinazoline-4-amine bis (4-methylbenzenesulfonic acid) salt. It has a wide range of uses and is often used as an active ingredient in the field of pharmaceutical research and development. It has been carefully designed to achieve specific physiological effects. This compound may have unique chemical structures and properties, and can precisely act on specific biological targets, such as proteins, enzymes or receptors. By interacting with the target or regulating key physiological processes in organisms, it can treat related diseases.
In the exploration of medicinal chemistry, such compounds may be lead compounds that have been structurally optimized and modified to enhance drug activity, selectivity and pharmacokinetic properties, making them more suitable for clinical application. Or they may be used to study the mechanism of disease occurrence, help understand complex physiological and pathological processes in organisms, and lay the foundation for the development of new therapeutic strategies. In experimental research, they can serve as tool compounds to help researchers explore specific biological pathways or cellular processes, and gain deeper insight into the mysteries of life. In short, they are of great significance in many fields such as medical research, and contribute to the development of human health.
What are the pharmacological effects of N- {3-Chloro-4- [ (3-Fluorobenzyl) Oxy] Phenyl} -6- [5- ({[2- (Methylsulfonyl) Ethyl] Amino} Methyl) Furan-2-Yl] Quinazolin-4-Amine Bis (4-Methylbenzenesulfonate)?
The name of this medicine is N- {3-chloro-4- [ (3-fluorobenzyl) oxy] phenyl} -6 - [5 - ({[2 - (methylsulfonyl) ethyl] amino} methyl) furan-2-yl] quinazoline-4-aminobis (4-methylbenzenesulfonic acid) salt. However, I do not know its exact pharmacological action, because there is no detailed record in the classics.
Ancient medicine, much according to the compendium of Materia Medica, typhoid miscellaneous diseases and other classics. However, the name of this medicine is uncommon and not recorded in the classics. Nowadays, medicine is developing rapidly, and new drugs are emerging in an endless stream, or they are newly made drugs in recent years.
According to its name, it contains quinazoline, furan and other structures. Quinazoline compounds often have anti-tumor, antibacterial and other activities; furans also have anti-inflammatory and antibacterial effects. This drug may have similar pharmacology, but there is no conclusive basis, so I dare not say it. Or it is a new achievement of scientific research. After experimental research, this complex compound is obtained, and specific pharmacological effects are expected. However, the specific effect depends on modern medical research data and clinical trial results, which cannot be speculated out of thin air.
What are the safety and side effects of N- {3-Chloro-4- [ (3-Fluorobenzyl) Oxy] Phenyl} -6- [5- ({[2- (Methylsulfonyl) Ethyl] Amino} Methyl) Furan-2-Yl] Quinazolin-4-Amine Bis (4-Methylbenzenesulfonate)?
The name of this drug is N- {3-chloro-4- [ (3-fluorobenzyl) oxy] phenyl} -6- [5- ({[2- (methylsulfonyl) ethyl] amino} methyl) furan-2-yl] quinazoline-4-amine, bis (4-methylbenzenesulfonic acid) salt. I have not seen ancient books on the safety and side effects of this drug. However, based on today's medical theory, the development of new drugs must undergo various tests to test their safety.
The process of observing the development of western drugs began with animal experiments to investigate their toxicity and pharmacology. Then human clinical trials were carried out in multiple phases. The first phase test is safe and tolerable, the second phase tests the efficacy and safety, and the third phase collects data to confirm the efficacy and risk. If this drug has undergone such strict tests, its safety may be well documented.
As for side effects, the drug is often biased. When treating the disease, it may disturb the health of the human body. Or there may be gastrointestinal discomfort, such as nausea, vomiting, diarrhea, etc.; or it may affect the blood system and cause changes in the number of blood cells; or there may be allergies, skin rashes, itching, and even respiratory tract obstruction. However, the specific side effects vary from individual to individual, and may be mild or severe. Doctors must weigh the pros and cons and handle them cautiously to ensure the well-being of patients.
N- {3-Chloro-4- [ (3-Fluorobenzyl) Oxy] Phenyl} -6- [5- ({[2- (Methylsulfonyl) Ethyl] Amino} Methyl) Furan-2-Yl] Quinazolin-4-Amine Bis (4-Methylbenzenesulfonate) What is the market outlook?
There is a product called N- {3-chloro-4- [ (3-fluorobenzyl) oxy] phenyl} -6- [5- ({[2- (methylsulfonyl) ethyl] amino} methyl) furan-2-yl] quinazoline-4-aminobis (4-methylbenzenesulfonate). The market prospect of this product is related to many things.
Looking at the current field of medicine, research and development is on the rise, and there is a great demand for novel and specific compounds. If this compound has unique pharmacological activity or shows good effect in the treatment of diseases, its future will be bright. For example, if it can accurately target specific disease targets, such as cancer, cardiovascular and cerebrovascular diseases, and the toxic and side effects are low, it will be favored by pharmaceutical companies, or it will lead many pharmaceutical companies to invest in research and development in order to develop finished drugs and bring them to the market, which will be quite profitable.
However, it also faces challenges. The synthesis process may be complicated and costly, which will affect the mass production and price. If the synthesis process is difficult to optimize, the cost will be difficult to reduce, and it will be at a disadvantage in market competition. Furthermore, the approval of new drugs is strict, and it needs to go through many clinical trials to prove that they are safe and effective before they can be marketed. If the clinical trial of this compound is frustrated, if the efficacy does not meet expectations, or there are serious adverse reactions, its market prospects will be like a bubble, and it will be in vain.
In summary, the market prospect of N- {3-chloro-4- [ (3-fluorobenzyl) oxy] phenyl} -6- [5- ({[2- (methylsulfonyl) ethyl] amino} methyl) furan-2-yl] quinazoline-4-aminobis (4-methylbenzenesulfonate) has both opportunities and challenges, depending on its pharmacological properties, synthesis costs and clinical trial results.